Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
ECVT vs IOSP
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
ECVT vs IOSP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $1.62B | $1.92B |
| Revenue (TTM) | $819M | $1.78B |
| Net Income (TTM) | $-63M | $117M |
| Gross Margin | 22.6% | 27.7% |
| Operating Margin | 15.4% | 8.7% |
| Forward P/E | 24.0x | 15.7x |
| Total Debt | $431M | $90M |
| Cash & Equiv. | $197M | $293M |
ECVT vs IOSP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ecovyst Inc. (ECVT) | 100 | 117.0 | +17.0% |
| Innospec Inc. (IOSP) | 100 | 100.8 | +0.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ECVT vs IOSP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ECVT is the clearest fit if your priority is growth exposure.
- Rev growth 2.7%, EPS growth -9.2%, 3Y rev CAGR -4.1%
- 2.7% revenue growth vs IOSP's -3.7%
- +117.2% vs IOSP's -14.2%
IOSP carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.70, yield 2.2%
- 83.8% 10Y total return vs ECVT's 14.1%
- Lower volatility, beta 0.70, Low D/E 6.3%, current ratio 2.79x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.7% revenue growth vs IOSP's -3.7% | |
| Value | Lower P/E (15.7x vs 24.0x) | |
| Quality / Margins | 6.6% margin vs ECVT's -7.7% | |
| Stability / Safety | Beta 0.70 vs ECVT's 0.90, lower leverage | |
| Dividends | 2.2% yield; 12-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +117.2% vs IOSP's -14.2% | |
| Efficiency (ROA) | 6.4% ROA vs ECVT's -4.2%, ROIC 10.7% vs 4.2% |
ECVT vs IOSP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ECVT vs IOSP — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ECVT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IOSP is the larger business by revenue, generating $1.8B annually — 2.2x ECVT's $819M. IOSP is the more profitable business, keeping 6.6% of every revenue dollar as net income compared to ECVT's -7.7%. On growth, ECVT holds the edge at +32.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $819M | $1.8B |
| EBITDAEarnings before interest/tax | $136M | $198M |
| Net IncomeAfter-tax profit | -$63M | $117M |
| Free Cash FlowCash after capex | $84M | $88M |
| Gross MarginGross profit ÷ Revenue | +22.6% | +27.7% |
| Operating MarginEBIT ÷ Revenue | +15.4% | +8.7% |
| Net MarginNet income ÷ Revenue | -7.7% | +6.6% |
| FCF MarginFCF ÷ Revenue | +10.2% | +4.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +32.6% | -2.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.3% | +167.7% |
Valuation Metrics
IOSP leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, IOSP's 8.4x EV/EBITDA is more attractive than ECVT's 14.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.6B | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $1.9B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | -24.07x | 16.63x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.04x | 15.66x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.52x |
| EV / EBITDAEnterprise value multiple | 13.99x | 8.37x |
| Price / SalesMarket cap ÷ Revenue | 2.24x | 1.08x |
| Price / BookPrice ÷ Book value/share | 2.82x | 1.37x |
| Price / FCFMarket cap ÷ FCF | 23.23x | 21.87x |
Profitability & Efficiency
IOSP leads this category, winning 7 of 7 comparable metrics.
Profitability & Efficiency
IOSP delivers a 8.2% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-10 for ECVT. IOSP carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to ECVT's 0.71x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -10.2% | +8.2% |
| ROA (TTM)Return on assets | -4.2% | +6.4% |
| ROICReturn on invested capital | +4.2% | +10.7% |
| ROCEReturn on capital employed | +4.6% | +11.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.71x | 0.06x |
| Net DebtTotal debt minus cash | $234M | -$203M |
| Cash & Equiv.Liquid assets | $197M | $293M |
| Total DebtShort + long-term debt | $431M | $90M |
| Interest CoverageEBIT ÷ Interest expense | 2.08x | — |
Total Returns (Dividends Reinvested)
ECVT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ECVT five years ago would be worth $12,247 today (with dividends reinvested), compared to $8,250 for IOSP. Over the past 12 months, ECVT leads with a +117.2% total return vs IOSP's -14.2%. The 3-year compound annual growth rate (CAGR) favors ECVT at 11.8% vs IOSP's -5.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +48.1% | +1.8% |
| 1-Year ReturnPast 12 months | +117.2% | -14.2% |
| 3-Year ReturnCumulative with dividends | +39.7% | -16.3% |
| 5-Year ReturnCumulative with dividends | +22.5% | -17.5% |
| 10-Year ReturnCumulative with dividends | +14.1% | +83.8% |
| CAGR (3Y)Annualised 3-year return | +11.8% | -5.8% |
Risk & Volatility
Evenly matched — ECVT and IOSP each lead in 1 of 2 comparable metrics.
Risk & Volatility
IOSP is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than ECVT's 0.90 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ECVT currently trades 98.3% from its 52-week high vs IOSP's 81.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.90x | 0.70x |
| 52-Week HighHighest price in past year | $14.94 | $95.55 |
| 52-Week LowLowest price in past year | $6.54 | $65.58 |
| % of 52W HighCurrent price vs 52-week peak | +98.3% | +81.3% |
| RSI (14)Momentum oscillator 0–100 | 68.0 | 61.9 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 223K |
Analyst Outlook
IOSP leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates ECVT as "Buy" and IOSP as "Hold". Consensus price targets imply 48.1% upside for IOSP (target: $115) vs -34.1% for ECVT (target: $10). IOSP is the only dividend payer here at 2.18% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $9.67 | $115.00 |
| # AnalystsCovering analysts | 6 | 9 |
| Dividend YieldAnnual dividend ÷ price | — | +2.2% |
| Dividend StreakConsecutive years of raises | 2 | 12 |
| Dividend / ShareAnnual DPS | — | $1.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.9% | 0.0% |
IOSP leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). ECVT leads in 2 (Income & Cash Flow, Total Returns). 1 tied.
ECVT vs IOSP: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ECVT or IOSP a better buy right now?
For growth investors, Ecovyst Inc.
(ECVT) is the stronger pick with 2. 7% revenue growth year-over-year, versus -3. 7% for Innospec Inc. (IOSP). Innospec Inc. (IOSP) offers the better valuation at 16. 6x trailing P/E (15. 7x forward), making it the more compelling value choice. Analysts rate Ecovyst Inc. (ECVT) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ECVT or IOSP?
On forward P/E, Innospec Inc.
is actually cheaper at 15. 7x.
03Which is the better long-term investment — ECVT or IOSP?
Over the past 5 years, Ecovyst Inc.
(ECVT) delivered a total return of +22. 5%, compared to -17. 5% for Innospec Inc. (IOSP). Over 10 years, the gap is even starker: IOSP returned +83. 8% versus ECVT's +14. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ECVT or IOSP?
By beta (market sensitivity over 5 years), Innospec Inc.
(IOSP) is the lower-risk stock at 0. 70β versus Ecovyst Inc. 's 0. 90β — meaning ECVT is approximately 30% more volatile than IOSP relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 6% versus 71% for Ecovyst Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ECVT or IOSP?
By revenue growth (latest reported year), Ecovyst Inc.
(ECVT) is pulling ahead at 2. 7% versus -3. 7% for Innospec Inc. (IOSP). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -916. 7% for Ecovyst Inc.. Over a 3-year CAGR, IOSP leads at -3. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ECVT or IOSP?
Innospec Inc.
(IOSP) is the more profitable company, earning 6. 6% net margin versus -9. 8% for Ecovyst Inc. — meaning it keeps 6. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ECVT leads at 9. 0% versus 8. 8% for IOSP. At the gross margin level — before operating expenses — IOSP leads at 27. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ECVT or IOSP more undervalued right now?
On forward earnings alone, Innospec Inc.
(IOSP) trades at 15. 7x forward P/E versus 24. 0x for Ecovyst Inc. — 8. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 48. 1% to $115. 00.
08Which pays a better dividend — ECVT or IOSP?
In this comparison, IOSP (2.
2% yield) pays a dividend. ECVT does not pay a meaningful dividend and should not be held primarily for income.
09Is ECVT or IOSP better for a retirement portfolio?
For long-horizon retirement investors, Innospec Inc.
(IOSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), 2. 2% yield). Both have compounded well over 10 years (IOSP: +83. 8%, ECVT: +14. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ECVT and IOSP?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ECVT is a small-cap quality compounder stock; IOSP is a small-cap deep-value stock. IOSP pays a dividend while ECVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.